We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson's Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs.
- Authors
Qiao, Chen-Meng; Huang, Wen-Yan; Zhou, Yu; Quan, Wei; Niu, Gu-Yu; Li, Ting; Zhang, Mei-Xuan; Wu, Jian; Zhao, Li-Ping; Zhao, Wei-Jiang; Cui, Chun; Shen, Yan-Qin
- Abstract
Increasing evidence suggests that the gut microbiota may represent potential strategies for Parkinson's disease (PD) treatment. Our previous research revealed a decreased abundance of Akkermansia muciniphila (Akk) in PD mice; however, whether Akk is beneficial to PD is unknown. To answer this question, the mice received MPTP intraperitoneally to construct a subacute model of PD and were then supplemented with Akk orally for 21 consecutive days. Motor function, dopaminergic neurons, neuroinflammation, and neurogenesis were examined. In addition, intestinal inflammation, and serum and fecal short-chain fatty acids (SCFAs) analyses, were assessed. We found that Akk treatment effectively inhibited the reduction of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and partially improved the motor function in PD mice. Additionally, Akk markedly alleviated neuroinflammation in the striatum and hippocampus and promoted hippocampal neurogenesis. It also decreased the level of colon inflammation. Furthermore, these aforementioned changes are mainly accompanied by alterations in serum and fecal isovaleric acid levels, and lower intestinal permeability. Our research strongly suggests that Akk is a potential neuroprotective agent for PD therapy.
- Subjects
PARKINSON'S disease; NEUROINFLAMMATION; NEUROGENESIS; LABORATORY mice; SHORT-chain fatty acids; CALPROTECTIN
- Publication
Brain Sciences (2076-3425), 2024, Vol 14, Issue 3, p238
- ISSN
2076-3425
- Publication type
Article
- DOI
10.3390/brainsci14030238